Authors Title E-pub date Journal namesort ascending
Motzer RJ, Hutson TE, Glen H, Michaelson MD, Molina A, Eisen T, et al. Lenvatinib, everolimus, and the combination in patients with metastatic ren... Wednesday, October 21, 2015 The Lancet Oncology
Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC Consensus on the management of intracranial germ-cell tumours Wednesday, September 16, 2015 The Lancet Oncology
Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, et al. Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorour... Saturday, May 16, 2015 The Lancet Oncology
Lamb AD, Bratt O Towards ""next-generation"" prostate cancer screening Saturday, November 14, 2015 The Lancet Oncology
Ajithkumar T, Parkinson C, Fife K, Corrie P, Jefferies S Evolving treatment options for melanoma brain metastases Monday, October 5, 2015 The Lancet Oncology
Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control Sunday, October 4, 2015 The Lancet Oncology
Emma L O'Dowd, Richard W Lee , Ahsan R Akram, Emily C Bartlett, Stephe... Defining the road map to a UK national lung cancer screening programme The Lancet Oncology
Wilkins A, Mossop H, Syndikus I, Khoo V, Bloomfield D, Parker C, et al. Hypofractionated radiotherapy versus conventionally fractionated radiothera... Tuesday, November 3, 2015 The Lancet Oncology
Wong HH, Halford S Dose-limiting toxicity and maximum tolerated dose: still fit for purpose? Monday, October 5, 2015 The Lancet Oncology
Treasure T, Rintoul RC, Macbeth F SABR in early operable lung cancer: time for evidence Wednesday, May 20, 2015 The Lancet Oncology

Pages